Evaluation of a Differentiated Point-of-care Active Case Finding & Management Model to Eliminate Mother-to-Child Transmission of HIV in Malawi
NCT06493357 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2426
Last updated 2025-09-26
Summary
Purpose: To conduct a hybrid effectiveness-implementation stepped-wedge trial to:
1. Estimate the effect of the PAC-Man model, compared to SOC, on the proportion of infants who receive timely EID testing.
2. Estimate the effect of the PAC-Man model, compared to SOC, on the proportion of pregnant and breastfeeding women living with HIV who receive guideline-adherent viral load testing.
3. Compare implementation outcomes between the PAC-Man model and SOC.
Participants: The total study sample size is 2,426, including 2,304 mother-infant pair (MIP) survey participants, 48 high-risk pregnant/breastfeeding women living with HIV for in-depth interviews (from high-risk MIPs who participated in a survey); 10 PMTCT policy makers and Ministry of Health (MOH)/ President's Emergency Plan for AIDS Relief (PEPFAR) implementing partner senior managers for key informant interviews; and about 48-64 professional and lay health providers for focus group discussions and implementation actor surveys.
To rigorously evaluate the PAC-Man model, investigators will use a hybrid (type 3) effectiveness-implementation incomplete stepped-wedge trial design. The hybrid incomplete stepped-wedge design is a rigorous quasi-experimental design that allows for incremental "rollout" of the PAC-Man model and serial measurement of both health outcomes (for infants and mothers in Objectives 1 and 2, respectively), as well as implementation outcomes (Objective 3). The incomplete stepped-wedge design is more efficient than a complete design, minimizes costs, and reduces participant burden, without sacrificing statistical precision. Using this design, sequential crossover from control (i.e., the SOC) to intervention (i.e., SOC plus the PAC-Man model) takes place at each 'step' using cluster randomization until all clusters (defined as a group of "sites," or health facilities plus the surrounding communities in its catchment area) receive the intervention. The 12 sites included in our study will be divided into 4 clusters of 3 sites each.
Conditions
- HIV Prevention
Interventions
- BEHAVIORAL
-
PAC-Man
PAC-Man represents an integrated DSD model for mothers and infants that brings the following three evidence-based practices into the community for EMTCT: 1) pediatric active case finding using novel POC EID technology; 2) same-day ART initiation for infants newly diagnosed with HIV infection; and 3) mVL testing and back-to-care services. PAC-Man uses a mobile approach to offer EMTCT services in the community and reach "high risk" MIPs. Delivering the PAC-Man model will be done under the auspices of routine care, applying an overarching implementation strategy of creating new mobile care teams equipped with new diagnostic technology who deploy the m-PIMA in community settings.
- BEHAVIORAL
-
Standard of Care
Routine care as provided by Ministry of Health.
Sponsors & Collaborators
-
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
collaborator NIH -
University of North Carolina, Chapel Hill
lead OTHER
Principal Investigators
-
Michael Herce, MD, MPH · University of North Carolina, Chapel Hill
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-03-27
- Primary Completion
- 2028-01-31
- Completion
- 2028-01-31
Countries
- Malawi
Study Locations
More Related Trials
-
Supporting Oral and Long-acting PrEP Decision Making Among Pregnant Women in Lilongwe, Malawi
NCT06397690 ·Status: COMPLETED ·Phase: NA
-
HIV Diagnosis in Hospitalized Malawian Infants
NCT01388452 ·Status: COMPLETED ·Phase: NA
-
Extended Infant Post-exposure Prophylaxis With Antiretrovirals to Reduce Postnatal HIV Transmission
NCT00115648 ·Status: COMPLETED ·Phase: PHASE3
-
Systems Analysis and Improvement to Optimize pMTCT
NCT02023658 ·Status: COMPLETED ·Phase: NA
-
Impact of Point-of-Care EID for HIV-Exposed Infants
NCT03824067 ·Status: COMPLETED ·Phase: NA
-
Primary HIV Prevention in Pregnant and Lactating Ugandan Women
NCT01882998 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Population-level Impact of PMTCT Option B+ in Zimbabwe
NCT03388398 ·Status: COMPLETED
-
Prenatal and Postnatal Studies of Interventions for Prevention of Mother-To-Child Transmission
NCT00028145 ·Status: COMPLETED
-
Optimizing Prevention and Care for Pregnant and Postpartum Adolescent Girls and Young Women With HIV in Tanzania
NCT06605053 ·Status: RECRUITING ·Phase: NA
-
HIV Point-of-Care Test Evaluation in Infants
NCT02545296 ·Status: COMPLETED ·Phase: NA
-
Enhanced Mentor Mother Strategy for Pregnant and Postpartum Women Living With HIV
NCT06999928 ·Status: RECRUITING ·Phase: NA
-
Point of Care Early Infant Diagnosis Patient Impact Study
NCT02744404 ·Status: COMPLETED
-
The Impact of Mentor Mothers on PMTCT Service Outcomes in Nigeria
NCT01936753 ·Status: COMPLETED ·Phase: NA
-
Preventing Unplanned Pregnancies in HIV Infected Zambian Couples
NCT00067522 ·Status: UNKNOWN ·Phase: NA
-
Mother Infant Retention for Health: MIR4Health
NCT01962220 ·Status: COMPLETED ·Phase: NA
-
HIV With Innovative Group Antenatal Care in Two African Countries
NCT02999334 ·Status: COMPLETED ·Phase: NA
-
Family-centered HIV Care, Viral Suppression and Retention in HIV-positive Children, Swaziland
NCT03397420 ·Status: COMPLETED ·Phase: NA
-
Measuring the Impact of Integrating Maternal and Newborn HIV Testing With Childhood Immunization Services
NCT02479659 ·Status: COMPLETED ·Phase: NA
-
ART Readiness in HIV-infected Pregnant Women
NCT02459678 ·Status: COMPLETED ·Phase: NA
-
Routine Use of Antiretroviral Therapy to Prevent Mother-to-Child HIV Transmission in the Kafue District of Zambia
NCT00753324 ·Status: COMPLETED ·Phase: PHASE4
-
Does Provision of Point of Care CD4 Technology and Early Knowledge of CD4 Levels Affect Early Initiation and Retention on Anti-retroviral Treatment (ART) in HIV Positive Pregnant Women in the Context of Option B+ for PMTCT?
NCT02070900 ·Status: UNKNOWN ·Phase: NA
-
HIV Treatment Reinitiation in Women Who Received Anti-HIV Drugs to Prevent Mother-to-Child Transmission of HIV
NCT00442962 ·Status: COMPLETED ·Phase: PHASE4
-
Prospective Cohort Evaluating Pregnancy Rates, PK Interactions Among HIV+ Women on EFV Initiating LNG Implant or DMPA
NCT03153709 ·Status: COMPLETED
-
Optimizing HIV Virologic Outcomes for Pregnant Women in Uganda
NCT04122144 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Measurement of Maternal Viral Load at Delivery to Optimise Post-natal Prophylaxis of HIV-exposed Newborns
NCT05017558 ·Status: UNKNOWN